newsfilter
← Latest News
PR Newswire·

BioMarin Completes Acquisition of Amicus Therapeutics

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) said today that it completed the previously announced agreement to acquire Amicus Therapeutics for $14.50 ...